Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public

Added by tchardes
Last modified by standudu
Group name EquipeELC
Item Type Journal Article
Title Prognostic Impact of pT3 Subclassification in a Multicentre Cohort of Patients with Urothelial Carcinoma of the Renal Pelvicalyceal System Undergoing Radical Nephroureterectomy: A Propensity Score-weighted Analysis After Central Pathology Review
Creator Seisen et al.
Author Thomas Seisen
Author Andrea Mari
Author Riccardo Campi
Author Benoit Peyronnet
Author Karim Bensalah
Author Nathalie Rioux-Leclercq
Author Christian Pfister
Author Françoise Gobet
Author Yves Allory
Author Evanguelos Xylinas
Author Yann Neuzillet
Author Jean-Luc Descotes
Author Géraldine Saada-Sebag
Author Jacques Irani
Author Céline Delpech-Debiais
Author Pierre Bigot
Author Caroline Eymerit
Author Sebastien Crouzet
Author Florence Mege-Lechevallier
Author Alain Ruffion
Author Myriam Decaussin-Petrucci
Author Stéphane Droupy
Author Pascal Roger
Author Xavier Durand
Author Philippe Camparo
Author Olivier Cussenot
Author Morgan Rouprêt
Abstract BACKGROUND: The current pathological tumour-node-metastasis (pTNM) classification for upper tract urothelial carcinoma (UTUC) does not include any risk stratification of pT3 renal pelvicalyceal tumours. OBJECTIVE: To assess the prognostic impact of pT3 subclassification in a multicentre cohort of patients with UTUC of the renal pelvicalyceal system undergoing radical nephroureterectomy (RNU). DESIGN, SETTING, AND PARTICIPANTS: Data from all consecutive patients treated with RNU for pT3 renal pelvicalyceal UTUC at 14 French centres from 1995 to 2013 were reviewed retrospectively. INTERVENTION: A central pathology review (CPR) was used to stratify pT3 patients into those with infiltration of the renal parenchyma on a microscopic level (pT3a) versus those with infiltration of the renal parenchyma visible on gross inspection of the resection specimen and/or invasion of peripelvic fat (pT3b). OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Inverse probability weighting (IPW)-adjusted Cox regression analyses were used to compare recurrence-free survival (RFS) and cancer-specific survival (CSS) between pT3a and pT3b patients. RESULTS AND LIMITATIONS: Overall, 202 patients were included and further stratified into pT3a (n = 98; 48.5%) and pT3b (n = 104; 51.5%) subgroups. Median time to follow-up in the weighted population was 68 (interquartile range, 50-95) mo. In IPW-adjusted Cox regression analyses, pT3b versus pT3a substage was associated with a significant adverse effect on RFS (hazard ratio [HR] = 2.02; 95% confidence interval [CI] = [1.36-3.01]; p < 0.001) and CSS (HR = 1.84; 95% CI = [1.20-2.82]; p = 0.005). The study is limited by its retrospective design. CONCLUSIONS: Using IPW-adjusted analyses after the CPR, we observed that RNU patients with pT3b renal pelvicalyceal UTUC had adverse prognosis as compared with those with pT3a disease. As such, this subclassification could help refine the current pTNM system for UTUC. PATIENT SUMMARY: In this report, we looked at the prognostic interest of stratifying patients with pT3 renal pelvicalyceal upper tract urothelial carcinoma based on the extent of local invasion. We found that those with extensive infiltration (pT3b) had adverse prognosis as compared with those with limited infiltration (pT3a). This information could be provided on pathology reports to further guide clinical decision making.
Publication European Urology Focus
Date 2020-10-23
Journal Abbr Eur Urol Focus
Language eng
DOI 10.1016/j.euf.2020.10.004
ISSN 2405-4569
Short Title Prognostic Impact of pT3 Subclassification in a Multicentre Cohort of Patients with Urothelial Carcinoma of the Renal Pelvicalyceal System Undergoing Radical Nephroureterectomy
Library Catalog PubMed
Extra 00000 PMID: 33463527
Tags Classification, clinic, Recurrence, Renal pelvis, Survival, Urothelial carcinoma
Date Added 2021/03/19 - 16:58:27
Date Modified 2021/04/21 - 13:17:16
Notes and Attachments PubMed entry (Attachment)


© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés